Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-29T07:07:37.530Z Has data issue: false hasContentIssue false
  • English
  • Français

Endemic Multidrug-Resistant Pseudomonas aeruginosa in Critically Ill Patients

Published online by Cambridge University Press:  02 January 2015

Bryan Ortega ,
A. B. Johan Groeneveld  and
Constance Schultsz
Bryan Ortega
Affiliation:
Intensive Care Unit, the Institute for Cardiovascular Research at the, Vrije Universiteit, Amsterdam, the Netherlands
A. B. Johan Groeneveld*
Affiliation:
Intensive Care Unit, the Institute for Cardiovascular Research at the, Vrije Universiteit, Amsterdam, the Netherlands
Constance Schultsz
Affiliation:
Department of Medical Microbiology, the Institute for Cardiovascular Research at theVrije Universiteit, Amsterdam, the Netherlands
*
Department of Intensive Care, Vrije Universiteit Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe the epidemiology of endemic multidrug-resistant Pseudomonas aeruginosa colonizations and infections in critically ill patients.

Design:

Prospective study on bacterial strain typing and retrospective cohort study of charts of patients in the intensive care unit (ICU).

Patients:

Fifty-three patients with P. aeruginosa isolated from clinical cultures in 2001 were selected, divided into those with P. aeruginosa in vitro resistant to at least two classes of antibiotics (multidrug-resistant, n = 18) and those susceptible to all or resistant to only one antibiotic (susceptible, n = 35).

Results:

Risk factors for multidrug-resistant P. aeruginosa included maxillary sinusitis, long-dwelling central venous catheters, prolonged use of certain antibiotics, a high lung injury score, and prolonged mechanical ventilation and duration of stay. The frequency of colonization (approximately 50%) versus infection (ie, ventilator-associated pneumonia) did not differ between the groups. On amplified fragment-length polymorphism analysis, 64% of the multidrug-resistant strains had been potentially transmitted via cross-colonization and 36% had probably originated endogenously. ICU mortality was 22% in the multidrug-resistant group and 23% in the susceptible group, although the duration of mechanical ventilation was longer in the former.

Conclusions:

Patients with sinusitis who stayed in the ICU longer, were ventilated longer because of acute lung injury, received antibiotics for longer durations, and had long-dwelling central venous catheters ran an elevated risk of acquiring multidrug-resistant P. aeruginosa. These patients did not have a higher mortality than patients with susceptible P. aeruginosa. Prevention of the emergence of multidrug-resistant strains requires changes in infection control measures and antibiotic policies in our ICU.

Type
Orginal Articles
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 10 , October 2004 , pp. 825 - 831
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Crouch Brewer, S, Wunderink, RG, Jones, CB, Leeper, KV Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa . Chest 1996;109:1019–1029.10.1378/chest.109.4.1019Google Scholar
2. Relio, J, Jubert, P, Valles, J, Artigas, A, Rué, M, Niederman, MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa . Clin Infect Dis 1996;23:973–978.10.1093/clinids/23.5.973Google Scholar
3. Bergmans, DC, Bonten, MJ, van Tiel, FH, et al. Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit. Thorax 1998;53:1053–1058.Google Scholar
4. Talon, D, Mulin, B, Rouget, C, Bailly, P, Thouverez, M, Viel, JE Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa . Am J Respir Crit Care Med 1998;157:978–984.10.1164/ajrccm.157.3.9702096Google Scholar
5. Trouillet, JL, Chastre, J, Vuagnat, A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531–539.10.1164/ajrccm.157.2.9705064Google Scholar
6. Bonten, MJ, Bergmans, DC, Speijer, H, Stobberingh, EE. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units: implications for infection control. Am J Respir Crit Care Med 1999;160:1212–1219.10.1164/ajrccm.160.4.9809031Google Scholar
7. Hanberger, H, Garcia-Rodriguez, JA, Gobernado, M, Goossens, H, Nilsson, LE, Struelens, MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. JAMA 1999;281:67–71.Google Scholar
8. Akça, O, Koltka, K, Uzel, S, et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. Anesthesiology 2000;93:638–645.Google Scholar
9. Berthelot, P, Grattard, F, Mahul, P, et al. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med 2001;27:503–512.10.1007/s001340100870Google Scholar
10. Bertrand, X, Thouverez, M, Talon, D, et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 2001;27:1263–1268.Google Scholar
11. Kollef, MH, Fraser, VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298–314.10.7326/0003-4819-134-4-200102200-00014Google Scholar
12. Aliaga, L, Mediavilla, JD, Cobo, F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia. J Med Microbiol 2002;51:615–619.10.1099/0022-1317-51-7-615Google Scholar
13. Livermore, DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002;34:634–640.Google Scholar
14. Trouillet, JL, Vuagnat, A, Combes, A, Kassis, N, Chastre, J, Gibert, C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 2002;34:1047–1054.10.1086/339488Google Scholar
15. Blot, S, Vandewoude, K, Hoste, E, Colardyn, F. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosa . J Hosp Infect 2003;53:18–24.10.1053/jhin.2002.1329Google Scholar
16. Gruson, D, Hilbert, G, Vargas, F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am J Respir Crit Care Med 2000;162:837–843.10.1164/ajrccm.162.3.9905050Google Scholar
17. Mohammedi, I, Ploin, D, Duperret, S, Chapuis, F, Petit, P. Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study. Intensive Care Med 2003;29:1164–1168.10.1007/s00134-003-1760-9Google Scholar
18. Speijer, H, Savelkoul, PH, Bonten, MJ, Stobberingh, EE, Tjhie, JH. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 1999;37:3654–3661.Google Scholar
19. Blot, S, Vandewoude, K, De Bacquer, D, Colardyn, F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:1600–1606.10.1086/340616Google Scholar
20. Ferreira, FL, Bota, DP, Bross, A, Mélot, C, Vincent, JL. Serial evaluation of the SOFA core to predict outcome in critically ill patients. JAMA 2001;286:1754–1758.10.1001/jama.286.14.1754Google Scholar
21. Murray, JF, Matthay, MA, Luce, JM, Fink, MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138:720–723.Google Scholar
22. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. Eleventh informational supplement M100-S11.Google Scholar
23. Koeleman, JG, Stoof, J, Biesmans, DJ, Savelkoul, PH, Vandenbroucke-Grauls CM. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii . J Clin Microbiol 1998;36:2522–2529.Google Scholar
24. Singh, N, Rogers, P, Atwood, CW, Wagener, MM, Yu, VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505–511.10.1164/ajrccm.162.2.9909095Google Scholar
25. Verwaest, C, Verhaegen, J, Ferdinande, R et al. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997;25:63–71.10.1097/00003246-199701000-00014Google Scholar
26. Masuda, N, Sakagawa, E, Ohya, S, Gotoh, N, Tsujimoto, H, Nishino, T. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa . Antimicrob Agents Chemother 2000;44:2242–2246.10.1128/AAC.44.9.2242-2246.2000Google Scholar
27. Booth, CM, Heyland, DK, Paterson, WG. Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence. Crit Care Med 2002;30:1429–1435.10.1097/00003246-200207000-00005Google Scholar
28. Harris, AD, Smith, D, Johnson, JA, Bradham, DD, Roghmann, MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002;34:340–345.10.1086/338237Google Scholar